Search

everythinglearnresearchcommunity

for

Search:↓

A simple method using the wash test and dermatoscopy can help differentiate between two hair loss conditions, androgenetic alopecia and chronic telogen effluvium.

Women find hair loss more distressing than men and often underestimate it, needing more public awareness and professional support.

Most women in the study lost hair due to stress, fever, childbirth, surgery, or thyroid issues, with low hemoglobin levels also common.

The best way to treat androgenetic alopecia, a common type of hair loss, is through early intervention and a comprehensive approach, but some supplements may reduce the effectiveness of medical treatments.

Telogen effluvium is the most common hair loss in women, often linked to low iron, while tight hairstyles and headscarves increase traction alopecia risk.

Trichoscopy is a quick and reliable way to diagnose hair loss in women.

A postmenopausal woman's hair loss and excess hair growth improved after surgery for ovarian hyperthecosis.

Androgenetic alopecia with telogen effluvium is the most common hair loss in women with hirsutism.

Minoxidil helps increase hair growth and density in people with hair loss, with higher concentrations giving better results.

Almost 40% of Greek women with acne show signs of androgen-related disorders, with adult women more likely affected.

Certain growth factors affect hair loss in women and could be targeted for treatment.

Hair loss in women can be treated with hormone therapy.

Many young women who donate blood have hormonal disorders like excess male hormones and PCOS.

Hair loss in women can be due to abnormal hair growth cycles or damaged hair follicles, with the most common type being androgenetic alopecia; treatment varies by cause, and the psychological impact is significant.

Alopecia in women can signal broader health issues and requires a thorough diagnosis to tailor treatments.

Flutamide may slightly improve hair loss in women, but finasteride does not work.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Routine thyroid tests for diffuse alopecia in women may not be necessary, but checking for iron deficiency anemia could be useful.

Low iron levels are linked to hair loss in women.

Finasteride improves acne and hair loss in women with normal testosterone.

The condition called 'acute diffuse and total alopecia of the female scalp' is actually a known condition named alopecia areata incognita.

A low-glycemic diet improved hormone levels and well-being in overweight women with high androgen levels.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Evaluate and manage androgen excess in women with a systematic approach, considering both physical and psychological impacts.

Alopecia treatments like 5α-reductase inhibitors and spironolactone are safe for breast cancer patients and high-risk women.

Adenosine complex helps increase hair thickness and density in hair loss.

Low iron levels may be linked to some types of hair loss in women.

AI can help track and improve hair loss treatment outcomes.